Document is current
Any future updates will be listed below
-
Authors
Murakami, Akira M. https://orcid.org/0000-0003-0760-386X
Kompel, Andrew J.
Engebretsen, Lars
Li, Xinning
Forster, Bruce B.
Crema, Michel D.
Hayashi, Daichi
Jarraya, Mohamed
Roemer, Frank W.
Guermazi, Ali
- License Information
-
More Information
Article History
Received: 15 May 2018
Accepted: 6 August 2018
First Online: 17 August 2018
Ethics approval and consent to participate
: This study was approved by the medical research ethics committee of the South-Eastern Norway Regional Health Authority (2011/388) and was exempt from Ethics Committee approval. Additional Institution Review Board (IRB) approval was obtained from Boston University (#H-36593). Informed written consent was waived since all epidemiological data was anonymized and unidentifiable. The use of anonymized imaging and demographic data for publication was approved by the IOC.
: Not applicable.
: Ali Guermazi is the President of Boston Imaging Core Lab (BICL), LLC, and a Consultant to MerckSerono, AstraZeneca, Pfizer, GE Healthcare, OrthoTrophix, Sanofi and TissueGene. Frank Roemer and Michel Crema are shareholders of BICL, LLC. Lars Engebretsen is a consultant to Arthrex and Smith and Nephew. Bruce Forster has an equity position with a private MRI clinic in Vancouver. Akira Murakami, Andrew J. Kompel, Xinning Li, Daichi Hayashi, and Mohamed Jarraya have nothing to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
